Kaiser Asks To Admit 'Snake Oil' Barb In Neurontin Trial

Law360, New York (March 15, 2010, 3:52 PM EDT) -- Plaintiffs in a trial over off-label marketing of Neurontin are asking the court to let them admit evidence that a Pfizer Inc.-employed doctor called the drug “the 'snake oil' of the 20th century.”

In the request, filed Sunday in the U.S. District Court for the District of Massachusetts, Kaiser Foundation Health Plan Inc. and Kaiser Foundation Hospitals said they should be able to admit the “snake oil e-mail,” sent in 1999 by Christopher Wohlberg, which the defendants allegedly did not produce for Kaiser during discovery in...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.